Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01743950
Title A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.